[exclusive] brief analysis of bidding trends in August 2018 (anti cancer drugs raise the tide of price reduction)

Among the developments in August 2018, Hainan, Shandong, Shanghai, etc are worthy of attention The small edition has summarized the pharmaceutical bidding developments in this month (August) and briefly analyzed some projects for reference (as of September 1): 1 Summary of bidding developments in various provinces and cities 2 Brief analysis ● this month, there is an inter provincial procurement alliance established in response to the notice on carrying out provincial special centralized procurement of anticancer drugs, with a total of 14 members from provinces and autonomous regions to jointly carry out the special procurement of imported anticancer drugs and promote the reasonable return of the price of imported anticancer drugs ● on August 28, 2018, Hainan Province announced the bid winning results of 2017 non essential drugs centralized procurement in Hainan Province In this result, a total of 8847 varieties with different product specifications of different enterprises won the bid Since September 16, 2018, the new bid began to trade and the old bid ceased to trade The directory distribution of each drug is as follows: Figure 1 ● on August 28, 2018, Shaanxi Province released the announcement of purchasing part of the shortlisted products through the generic drug quality and efficacy consistency evaluation variety sunshine The variety that passed the consistency evaluation announced in this announcement is tinofibrate fumarate dipivoxil tablets of Zhengda Tianqing, with the purchase price limit of 430 yuan ● on August 16, 2018, Shanghai announced the bid winning results of the third batch of centralized bidding procurement for medical institutions The product specifications of 21 different enterprises are published in this result Data source: Yaozhi bid winning query information database statement: this point of view only represents the author and does not represent the position of yaozhi.com, welcome to exchange and supplement in the message area; if you need to reprint, please be sure to indicate the author and source of the article.